±±Ê¦´óϸ°ûÉúÎïѧ£¨ÀúÄêÊÔÌâ×ܽᣩ ~`M>&E@Y_/
Ò»¡¢ Ãû´Ê½âÊÍ£º jH26-b<
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© !HyPe"`oL
2£® PCR£¨96£© y\ L$8BSL
3£® ·ºËØ£¨ubquitin£©£¨96£© ^mr#t #[e
4£® °é·Ö×Ó£¨chapron£©£¨96£© !<\"XxK+l
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© ~_v?M%5i
6£® DG£IP3£¨96£© d5$2*h{^v
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© ^znj J\
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© $c4Q6w
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© Z}_{@|
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© 5m2(7FC%su
11£® Transformation£¨92£© <1#v}epD#
12£® TransfectionתȾ£¨92£© 5HP6o
13£® TranscytosisתÒÆ×÷Óã¨92£© It,m %5
Py
14£® Transductionתµ¼£¨92£© /VB n
15£® Transdetermination£¨92£© X51pRP $R
16£® Transdifferentiation£¨92£© D)z'FOaI
17£® Transgenic animalת»ùÒò¶¯Î92£© R:SFj!W1
18£® Rb£1£¨92£© K|$Dnma^n
19£® P53£¨92¡¢91£© jSbO1 go#
20£® C£jun£¨92£© s6<`#KFAg
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Rfh#JO@%[
22£® °ûÄÚÌ壨99£© cF{5[?wS
23£® Cyclin dependent kinase inhibitor(CDKI)(99) #iD5&
klo\
24£® G£protein£¨91£© \.p{~Hv
25£® Restriction point£¨91£© ?CGbnXZ4Ug
26£® Antipost£¨91£© NyU~8?bp
27£® Capping£¨91£© 3c] oU1GfF
28£® TATAbox£¨91£© h-`Jd>u"
29£® cDNA library£¨90£© vUBkoC2Q
30£® Aritotic apparatus£¨90£© 3XY;g{`=q
31£® ¿çĤÐźŠtransmembrane signal£¨90£© '9cShe
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© >*rsR R
33£® Nuclear lamina£¨90£© !fF1tW
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© dK|6p_
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© *44^M{ti<
36£® ϸ°û·Ö»¯£¨00£© hEAt4z0P
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© :3F&NsgHH
38£® ¿Ë¡£¨00£© j3|Ek
39£® »ùÒò×飨00£© +@D [%l|
40£® Caspase£¨00£©
cl4`FU
41£® ת¼Òò×Ó£¨00£© p]=a:kd4J
42£® ÅßÌ¥¸Éϸ°û£¨01£© b0Pq
P<{ t
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© FyY
D7E
44£® DNAоƬ£¨01£© }.O,P'k
¶þ¡¢ ÎÊ´ðÌ⣺ K~"uZa^s
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© L?!*HS7m
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© 8_0j^oh
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© 1iBOf8
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© pk2OZ,14Mj
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© PY=(|2tb4
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© Cv{>|g#
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© :-HVK^$%
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© (Qmpz
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© q9rY++Tv
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© X3zkUMk
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© In)8AK(Hw
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© @,0W(
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© :'RmT3
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© W0%cJ8~
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© 2lNZwV7
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© t|q@~B
:
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£©
Z
4,nl
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© M qq/k J
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© u*:B 9E
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© Htd-E^/
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£© "H I&dC
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© ^hPREbD+f
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ?,8|K B
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© ;]AJ_h(<`
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© +\~.cP7[
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© gZbC[L
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© AwrW!)n}
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© @H%)!f]zWt
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© B:5\+_a!
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£© zzlV((8~
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© ._2#89V
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© k=D_9_
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© Y*0 AS|r!
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© rN0G|
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©